COVID-19 Coagulopathy: Whom to Anticoagulate and How? What Agents to…

Rush University Medical Center

S. Jain

New European Guidelines on Pulmonary Embolism: What Has Changed and …

PERT Consortium 2021

S. Konstantinides

Bleeding Management and Use of Anticoagulants: Panel Discussion

PERT Consortium 2021

G. Piazza, M. McDaniel, M. Huisman, D. Siegal, C. Pollack

Five Things Every Internist Should Know About Anticoagulants

McMaster University Department of Medicine

S. Mithoowani

Pulmonary Embolism During Pregnancy

Pulmonary Embolism 2016

J. Bartholomew

TCT 2022: Why Intervene on Submassive Pulmonary Embolism Patients?

TCT 2022 Conference Coverage

W. Jaber

Extended Anticoagulation for VTE

Jeffrey Weitz

Pulmonary Hypertension Due to Lung Disease / Chronic Pulmonary Embol…

Scripps Health

K. Fan

Pulmonary Embolism: Where Are We in 2024?

UPMC

B. Rivera-Lebron

Catheter-Based Interventions for Acute Pulmonary Embolism: What Are …

Mount Sinai Endovascular Fellows Course

J. Giri

Update on HI-PEITHO - A Landmark Clinical Trial in PE

PERT Consortium 2022

K. Rosenfield

Long Term Anticoagulation - How and For How Long?

Pulmonary Embolism Symposium (PERT 2017)

PE - The Great Masquerader: A Disease of Many Faces: Cases Where I W…

Pulmonary Embolism 2016

V. Tapson

Management of Acute Pulmonary Embolism: How Long Do You Treat?

NYU Langone

N. Amoroso

Pulmonary Embolism: Risk Stratification and Management

Talal Dahhan

Right Heart Failure Secondary to Non-Group 1 PH

Mayo Clinic Pulmonary and Critical Care Educational Series

H. Cajigas

Role of Thrombolysis for Patients With Acute Intermediate-Risk Pulmo…

CHEST 2022 Coverage

B. Dalal

Diagnosis of Pulmonary Embolism

NY Endovascular Summit

A. Jacobi

Triaging Acute Pulmonary Embolism for Home Treatment or Simplified P…

PERT Consortium 2021

M. Huisman

Panel Discussion: Acute vs Chronic Changes in PE, Anticoagulation Du…

The North American Thrombosis Forum (NATF)

G. Piazza, J. Rodriguez-Lopez, B. Bikdeli, A. Witkin, F. Rahaghi, A. Wong